Yes holding the gains well.
"If the company can show that it can make its cells at industrial scale under GMP then it will be in a position to be a genuine Stem Cell Revolutionary, combining the known therapeutic power of MSCs with the low cost of iPS cells. This will suggest to potential commercial partners that they can work with Cynata without having to worry about GMP issues."
Tick. This is
This is the positive. Any noises about devs with potential partners and it will rerate. The longer from the last announcement the closer to the next. Risky to be out.
Market cap below $80m - so cheap, page-10
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.010(5.56%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.5¢ | 18.0¢ | $9.062K | 48.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 104632 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 3 | 1 |
View Market Depth
| Last trade - 14.37pm 12/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |